What do you need to know about the Guillain-Barré disease and Johnson and Johnson vaccines
• 4 years agoThis is not the first vaccine that has been linked to Guillain-Barré, although the risk appears to be tiny.
COVID-19 Fact Check: What does science say about mixing vaccines?
Abigailb • 4 years agoWhile the studies show positive results of mixing AstraZeneca and Pfizer, there are still doubts that linger.
Explained: Johnson & Johnson says its COVID-19 vaccine is effective against Delta variant; what this means
Fp Staff • 4 years agoJ&J has indicated that it is in talks with the Indian government to bring its vaccine to the country of 1.3 billion people
COVID-19 vaccines were developed in under a year, HIV still awaits a vaccine four decades later
• 4 years agoLast year, a study in South Africa involved the only vaccine candidate that showed protection, was ultimately not effective enough.
Pfizer, Moderna, Johnson and Johnson vaccines effective against B1617 variant of COVID-19, says top US health official
• 4 years ago"The data is coming in, and it looks very encouraging that the US-approved vaccines do have effectiveness against this variant called B1617," Dr Francis Collins, Director of the National Institute of Science said
US to approve Pfizer-BioNTech COVID-19 vaccine for kids aged 12 and above by next week
• 4 years agoModerna and Johnson & Johnson are also conducting trials of its vaccine in teens and younger children as well.
US to resume Johnson & Johnson COVID-19 vaccinations despite rare risk of blood clots
• 4 years agoFederal health officials decided that J&J's one-and-done vaccine is critical to fight the pandemic after scientific advisers said its benefits outweigh the risks
India fast-tracks EUA for foreign-produced COVID vaccines amid spike in cases: A look at all the options
Fp Staff • 4 years agoThe Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin
Russia's Sputnik V COVID-19 vaccine gets expert panel nod for emergency use in India
Tech2 News Staff • 4 years agoDr Reddy's conducted the bridge trials in India and will distribute some 100 million doses of the vaccine in India.
Johnson and Johnson expects COVID-19 vaccine results soon but lags behind in production
• 5 years agoIn 2021, Johnson & Johnson promised to supply 200 million doses to Covax and will supply another 300 million to Covax in 2022.